Ansa Biotechnologies
Ansa Biotechnologies is a YC Winter 2020 (W20) company. Based in Emeryville, CA, USA. Team of 72.
About Ansa Biotechnologies
Summary
Ansa Biotechnologies builds an enzymatic DNA synthesis platform that produces custom DNA fragments and constructs for biological research and biotechnology. Where conventional chemical synthesis methods struggle with complex sequences, repeats, and GC-rich regions, Ansa synthesizes directly up to 900 bp and delivers constructs up to 50 kb without requiring redesign cycles or multi-vendor assembly. Researchers and biotech teams use it to move from sequence design to functional construct in a single order.
Go-to-market
Customers in biological research, therapeutics, diagnostics, and biomanufacturing order custom DNA products directly through Ansa's platform, choosing from clonal DNA, fragments, vectors, and scale-up offerings via a self-serve ordering workflow.
From the Y Combinator listing
Next-generation DNA synthesis using enzymes
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Facts
- Healthcare / Healthcare -> Industrial Bio
- Emeryville, CA, USA
- 72
- Active
- Early
Founders (2)
- Dan Lin-Arlow
- Sebastian Palluk
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works